Home Adendra Therapeutics

Adendra Therapeutics

In operation
Series A
Developer of Novel Immunotherapies
Basic
Enterprise Profile

Basic Information

Adendra Therapeutics was spun out from the Francis Crick Institute by ATP in 2021. It aims to create a new type of immunotherapy. With new insights into dendritic cell biology, Adendra is committed to discovering and developing novel small molecules and biologics for cancer and other diseases.
Adendra Therapeutics Ltd.
London,England,United Kingdom
less than 15 people
January 01, 2021
--

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Immunological Techniques
Concept
Tumor Immune System Diseases Therapeutic Products
Application Scenarios
Innovative Drugs